BSECompany Update3d ago · 22 Sept 2026, 12:23 pm

Intimation Under Regulation 30 of SEBI (LODR) Regulations, 2015, Receipt of Significant International Purchase Order.

Shelter Pharma Ltd · 543963

✦ AI Summary▲ PositiveOrder Win

Shelter Pharma Ltd has received a significant international purchase order from Berlin International Company for the supply of nutraceutical products, valued at USD 10,150. This order is expected to have a positive impact on the company's business performance and revenue growth.

Analysis Scores

Earnings Impact8/10
Growth Catalyst9/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment9/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Shelter Pharma Ltd - 543963 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

Attachments (1)

📄

9a95ce71-9ef1-4d31-aced-3def29959020.pdf

pdf

Download →
View document text
Date: 22nd September, 2026 BSE Limited, Floor 25, P J Towers, Dalal Street, Mumbai – 400001 Scrip ID: SHELTER Scrip Code: 543963 Subject: Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 –– Receipt of Significant International Purchase Orders. Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI read with Schedule III (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform that the Company has received export order from Berlin International Company in the normal course of business. The receipt of this export order is in line with the Company's strategic focus on diversifying its revenue base and strengthening its presence in international markets. This is expected to have a positive impact on the Company's overall business performance. The receipt of this order marks a positive development for Shelter Pharma Limited as the Company continues to broaden its market reach across the global nutraceutical sector. Supported by its research and development capabilities, enables the Company to develop and offer products in line with evolving market and customer requirements. The order is expected to contribute to the Company’s business and revenue growth upon execution and further expand its international customer base. The association with an overseas customer also provides an opportunity for Shelter Pharma to make use of its R&D expertise to develop and offer innovative products suited to international market requirements. The Company will continue to focus on research and development, product quality and timely execution while exploring opportunities to further expand its presence across global nutraceutical and healthcare markets. The details pursuant to SEBI Listing Regulations, 2015 and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026 is mentioned in the Annexure A. Kindly take the above information on record. Thanking You, FOR SHELTER PHARMA LIMITED MUSTAQIM NISARAHMED SABUGAR MANAGING DIRECTOR DIN: 01456841 Place: Ahmedabad Annexure - A Details pursuant to Regulation 30 of SEBI Listing Regulations, 2015 and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026 Sr. Particulars Details 1 Name of the entity awarding the order Berlin International Company 2 Significant terms and conditions of The Company has received purchase order awarded in brief orders for supply of Nutraceutical products namely:  D3 CURE 50 ML Qty 3500x2.90 – (USD 10,150) 3 Whether order have been awarded by International Entity domestic/ international entity 4 Nature of order; Normal course of business 5 Whether domestic or international International 6 Time period by which the order is to The order is to be executed within the be executed mutually agreed timelines as per purchase order schedule. 7 Broad consideration or size of the USD 10,150 or Rs. 9,72,360.86 order (Rupees Nine Lakhs Seventy-Two Thousand Three Hundred and Sixty and Eighty-Six Paise only) 8 Whether the promoter/ promoter No, the promoter / promoter group / group / group companies have any group companies do not have any interest in the entity that awarded the interest in the entity. order? If yes, nature of interest and details thereof 9 Whether the order would fall within No, the transaction does not fall under related party transactions? related party transactions.